Table 1.

Cell cycle distribution and caspase-3 activation of resveratrol- and paclitaxel-treated Ramos cells

G0/G1SG2-MSub-G0Caspase-3
Control32.6 ± 4.719.8 ± 3.238.4 ±3.67.6 ± 4.27.2 ± 3.1
Resveratrol (10 μm)29.0 ± 6.313.1 ± 2.846.4 ± 4.610.4 ± 3.46.9 ± 2.2
Paclitaxel (10 nm)14.2 ± 2.915.3 ± 4.156.8 ± 3.114.6 ± 4.615.2 ± 3.8
Resveratrol + paclitaxel13.6 ± 4.211.3 ± 3.614.3 ± 2.958.4 ± 3.8*52.3 ± 4.6*
  • Note: The second aliquot of the samples in Fig. 2 was stained with FITC-labeled anti-active caspase-3 mAb for the measurement of the levels of active caspase-3. Both assays were analyzed by flow cytometry. Results are means ± SD of four independent experiments.

  • * P < 0.05, significant compared with paclitaxel treatment alone.